US$ 28.30
foxo4 dri senolytic human trials FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4 10mg Vial - Buy
Description
Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors

Unlike most regulatory peptides, the molecule resists gastric proteolysis intact a feature that has driven much of the oral-administration preclinical work and that distinguishes it from injectable-only fragments such as TB-500

Resveratrol (RSV) has been shown to be effective at removing excess reactive oxygen species (ROS) or reactive nitrogen species generation in the central nervous system (CNS), but the delivery of RSV into the brain through systemic administration is inefficient

This product is prescribed by a licensed healthcare provider based on the individual needs
